Prognostic factors in mucoepidermoid carcinoma of the salivary glands

被引:147
作者
McHugh, Catherine H. [1 ,2 ]
Roberts, Dianna B. [1 ]
El-Naggar, Adel K. [3 ]
Hanna, Ehab Y. [1 ]
Garden, Adam S. [4 ]
Kies, Merrill S. [5 ]
Weber, Randal S. [1 ]
Kupferman, Michael E. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[2] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
关键词
mucoepidermoid carcinoma; salivary gland carcinoma; parotid gland; submandibular gland; treatment intensification; PHASE-II; CONCURRENT CHEMORADIOTHERAPY; ONCOLOGY-GROUP; TUMORS; CHEMOTHERAPY; HEAD; NECK; MALIGNANCIES; MANAGEMENT; CISPLATIN;
D O I
10.1002/cncr.26697
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Mucoepidermoid carcinoma (MEC) is the most common malignancy of the major salivary glands. Prior reports noted histological grade and tumor stage as consistently important prognostic factors. This study reviewed the experience of patients with MEC at the University of Texas MD Anderson Cancer Center to determine the impact of clinical and pathologic findings on disease outcomes. METHODS: A retrospective clinical review was performed of patients with salivary gland MEC treated at a tertiary cancer center from 1990 to 2007. RESULTS: A total of 125 patients were included. The 5-year overall survival and disease-free survival of all patients were 79.3% and 76.5%, respectively. Patients with low- and intermediate-grade disease had significantly better overall survival and disease-free survival than patients with high-grade disease, but no difference in survival rates was found between low- and intermediate-grade disease. Pathologic results of positive lymph nodes, extracapsular lymph node spread, and perineural invasion were all found to be poor prognostic indicators. On multivariate analysis, advanced disease stage and perineural invasion were found to be the most significant prognostic factors. CONCLUSIONS: Patients with either low- or intermediate-grade tumors uniformly have favorable local control and survival. High histological grade, advanced stage, perineural invasion, positive surgical margins, and submandibular location all portend for poor outcomes in MEC. Further advances in therapy are needed to improve outcomes for high-grade and advanced-stage disease. Cancer 2012. (c) 2011 American Cancer Society.
引用
收藏
页码:3928 / 3936
页数:9
相关论文
共 29 条
[21]   Incidence rates of salivary gland tumors: Results from a population-based study [J].
Pinkston, JA ;
Cole, P .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1999, 120 (06) :834-840
[22]   THE IMPORTANCE OF CLINICAL STAGING OF MINOR SALIVARY-GLAND CARCINOMA [J].
SPIRO, RH ;
THALER, HT ;
HICKS, WF ;
KHER, UA ;
HUVOS, AH ;
STRONG, EW .
AMERICAN JOURNAL OF SURGERY, 1991, 162 (04) :330-336
[23]   MUCOEPIDERMOID CARCINOMA OF SALIVARY-GLAND ORIGIN - CLINICOPATHOLOGIC STUDY OF 367 CASES [J].
SPIRO, RH ;
HUVOS, AG ;
BERK, R ;
STRONG, EW .
AMERICAN JOURNAL OF SURGERY, 1978, 136 (04) :461-468
[24]   Outcomes of Postoperative Concurrent Chemoradiotherapy for Locally Advanced Major Salivary Gland Carcinoma [J].
Tanvetyanon, Tawee ;
Qin, Dahui ;
Padhya, Tapan ;
McCaffrey, Judith ;
Zhu, Weiwei ;
Boulware, David ;
DeConti, Ronald ;
Trotti, Andy .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (07) :687-692
[25]   The prognostic role of comorbidity in salivary gland carcinoma [J].
Terhaard, Chris H. J. ;
van der Schroeff, Marc P. ;
van Schie, Kim ;
Eerenstein, Simone E. J. ;
Lubsen, Herman ;
Kaanders, Johannes H. A. M. ;
Smeele, Ludwig E. ;
Burlage, Fred R. ;
van den Ende, Piet L. ;
de Jong, Robert J. Baatenburg .
CANCER, 2008, 113 (07) :1572-1579
[26]   CRTCI/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors:: Implications for histogenesis and biologic behavior [J].
Tirado, Yamilet ;
Williams, Michelle D. ;
Hanna, Ehab Y. ;
Kaye, Frederic J. ;
Batsakis, John G. ;
El-Naggar, Adel K. .
GENES CHROMOSOMES & CANCER, 2007, 46 (07) :708-715
[27]  
Vander Poorten VLM, 2000, CANCER-AM CANCER SOC, V89, P1195, DOI 10.1002/1097-0142(20000915)89:6<1195::AID-CNCR2>3.0.CO
[28]  
2-J
[29]   CISPLATIN, DOXORUBICIN, AND 5-FLUOROURACIL CHEMOTHERAPY FOR SALIVARY-GLAND MALIGNANCIES - A PILOT-STUDY OF THE NORTHERN-CALIFORNIA-ONCOLOGY-GROUP [J].
VENOOK, AP ;
TSENG, A ;
MEYERS, FJ ;
SILVERBERG, I ;
BOLES, R ;
FU, KK ;
JACOBS, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (06) :951-955